Preclinical Evaluation Platform for Drug Candidates

The preclinical evaluation platform supports the authorization process of novel medicinal products by providing basic data from animal models. The platform comprises three test clusters: (i) ADME (absorption, distribution, metabolisation, elimination) characteristics, (ii) doses finding, and (iii) efficacy of candidate compounds (in dedicated animal disease models and controls). As a technical specificity the platform is using imaging methods (PET, MRI) for the establishment of kinetic and distribution data sets.


  • Prof. Dr. Andreas Bauer

    Institute of Neuroscience and Medicine

    Forschungszentrum Jülich

    52425 Jülich

    Phone: +49 2461 61-4898
    Fax: +49 2461 61-2990
    E-Mail: Contact


Edgar Specker, FMP

Franziska Wedekind, FZJ 

Claus-Michael Lehr und
Rolf Hartmann, HZI/HIPS

Michael Bader, MDC